Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	CCDC88C KATNAL2 MYO1E CENPF ARL8B CFL2 SPTB KTN1 SYNE2 PHACTR4 LRRK2 AFDN ACTN4 ARL8A DMD JAKMIP2 MYO16 VCL	2.68e-06	1099	93	18	GO:0008092
GeneOntologyMolecularFunction	actin binding	MYO1E CFL2 SPTB SYNE2 PHACTR4 LRRK2 AFDN ACTN4 DMD MYO16 VCL	1.40e-05	479	93	11	GO:0003779
GeneOntologyMolecularFunction	mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity	MAN2A2 MAN2A1	2.15e-05	2	93	2	GO:0004572
GeneOntologyMolecularFunction	actin filament binding	MYO1E CFL2 SPTB AFDN ACTN4 MYO16 VCL	9.25e-05	227	93	7	GO:0051015
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 CCDC88C HTR2B TRIO KALRN SYDE2 LRRK2 HERC2 ALS2CL PREX1	1.25e-04	507	93	10	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 CCDC88C HTR2B TRIO KALRN SYDE2 LRRK2 HERC2 ALS2CL PREX1	1.25e-04	507	93	10	GO:0030695
GeneOntologyMolecularFunction	dynein light intermediate chain binding	CCDC88C DNAH17 DYNC1H1	2.94e-04	28	93	3	GO:0051959
GeneOntologyMolecularFunction	transition metal ion binding	AARS1 TRAF5 ATP7A RNPEP TRIM35 ENPP3 CYP17A1 ZMYND8 ENPP5 HERC2 DMD ECE1 TF AR PDXK	3.75e-04	1189	93	15	GO:0046914
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	CCDC88C TRIO KALRN HERC2 ALS2CL PREX1	7.41e-04	231	93	6	GO:0005085
GeneOntologyMolecularFunction	zinc ion binding	AARS1 TRAF5 RNPEP TRIM35 ENPP3 ZMYND8 ENPP5 HERC2 DMD ECE1 AR PDXK	8.67e-04	891	93	12	GO:0008270
GeneOntologyMolecularFunction	mannosyl-oligosaccharide mannosidase activity	MAN2A2 MAN2A1	9.42e-04	10	93	2	GO:0015924
GeneOntologyMolecularFunction	dystroglycan binding	DMD VCL	1.37e-03	12	93	2	GO:0002162
GeneOntologyMolecularFunction	pyrophosphatase activity	PRUNE2 KATNAL2 ATP7A MYO1E ARL8B ENPP3 SMCHD1 LRRK2 ENPP5 ARL8A DYNC1H1	1.78e-03	839	93	11	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	PRUNE2 KATNAL2 ATP7A MYO1E ARL8B ENPP3 SMCHD1 LRRK2 ENPP5 ARL8A DYNC1H1	1.80e-03	840	93	11	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	PRUNE2 KATNAL2 ATP7A MYO1E ARL8B ENPP3 SMCHD1 LRRK2 ENPP5 ARL8A DYNC1H1	1.80e-03	840	93	11	GO:0016818
GeneOntologyMolecularFunction	GTPase activator activity	STARD13 HTR2B SYDE2 LRRK2 ALS2CL PREX1	1.95e-03	279	93	6	GO:0005096
GeneOntologyMolecularFunction	signaling receptor complex adaptor activity	SHANK1 LRRK2 CARD10	2.04e-03	54	93	3	GO:0030159
GeneOntologyMolecularFunction	alpha-mannosidase activity	MAN2A2 MAN2A1	2.17e-03	15	93	2	GO:0004559
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1E DNAH17 DYNC1H1 MYO16	2.26e-03	118	93	4	GO:0003774
GeneOntologyMolecularFunction	mannosidase activity	MAN2A2 MAN2A1	2.47e-03	16	93	2	GO:0015923
GeneOntologyMolecularFunction	protein domain specific binding	SHANK1 CCDC88C CTR9 CEP250 ZMYND8 TJP2 AFDN CARD10 DMD CDC5L AR	2.47e-03	875	93	11	GO:0019904
GeneOntologyBiologicalProcess	protein localization to endoplasmic reticulum exit site	MIA3 LRRK2 SEC16A	4.89e-06	8	93	3	GO:0070973
GeneOntologyBiologicalProcess	cytoskeleton-dependent intracellular transport	CCDC88C ARL8B IFT172 SYNE2 ACTN4 ARL8A IFT80 DYNC1H1	8.13e-06	225	93	8	GO:0030705
GeneOntologyBiologicalProcess	microtubule-based movement	CCDC88C AKAP4 ARL8B IFT172 KTN1 DNAH17 SYNE2 ARL8A IFT80 DYNC1H1 BBOF1	1.36e-05	493	93	11	GO:0007018
GeneOntologyBiologicalProcess	microtubule-based process	CCDC88C KATNAL2 AKAP4 ARL8B IFT172 CEP250 KTN1 DNAH17 SYNE2 CCDC78 NINL ARL8A IFT80 ZW10 DYNC1H1 BBOF1	1.88e-05	1058	93	16	GO:0007017
GeneOntologyBiologicalProcess	supramolecular fiber organization	SHANK1 CCDC88C KATNAL2 MIA3 ATP7A MYO1E USP9X IFT172 CFL2 SPTB KANK4 ACTN4 TF PREX1 DYNC1H1	2.34e-05	957	93	15	GO:0097435
GeneOntologyBiologicalProcess	epithelial cell development	CCDC88C BCL11B MYO1E TJP2 AFDN DMD AR VCL	2.95e-05	269	93	8	GO:0002064
GeneOntologyBiologicalProcess	protein localization to cell junction	SHANK1 KALRN TJP2 AFDN ACTN4 VCL	5.62e-05	148	93	6	GO:1902414
GeneOntologyBiologicalProcess	neuron projection morphogenesis	SHANK1 BCL11B ATP7A RAPH1 TRIO KALRN USP9X LRRK2 AFDN DMD ECE1 MYO16 VCL	6.19e-05	802	93	13	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	SHANK1 BCL11B ATP7A RAPH1 TRIO KALRN USP9X LRRK2 AFDN DMD ECE1 MYO16 VCL	7.65e-05	819	93	13	GO:0120039
GeneOntologyBiologicalProcess	cell morphogenesis	SHANK1 CCDC88C BCL11B ATP7A RAPH1 TRIO KALRN USP9X LRRK2 AFDN DMD ECE1 AR MYO16 VCL BRWD1	8.04e-05	1194	93	16	GO:0000902
GeneOntologyBiologicalProcess	central nervous system development	AARS1 PTCHD1 KLK6 BCL11B ATP7A CENPF USP9X IFT172 SYNE2 LRRK2 SEC16A AFDN IFT80 DMD MYO16 PHLPP2	8.28e-05	1197	93	16	GO:0007417
GeneOntologyBiologicalProcess	cell projection morphogenesis	SHANK1 BCL11B ATP7A RAPH1 TRIO KALRN USP9X LRRK2 AFDN DMD ECE1 MYO16 VCL	8.33e-05	826	93	13	GO:0048858
GeneOntologyBiologicalProcess	brain development	AARS1 PTCHD1 BCL11B ATP7A CENPF USP9X IFT172 SYNE2 LRRK2 SEC16A AFDN MYO16 PHLPP2	1.23e-04	859	93	13	GO:0007420
GeneOntologyBiologicalProcess	microtubule-based transport	CCDC88C ARL8B IFT172 SYNE2 ARL8A IFT80 DYNC1H1	1.49e-04	253	93	7	GO:0099111
GeneOntologyBiologicalProcess	organelle assembly	AKAP4 CENPF ARL8B USP9X IFT172 CFL2 CEP250 DNAH17 SYNE2 CCDC78 LRRK2 IFT80 AR DYNC1H1 BBOF1	1.65e-04	1138	93	15	GO:0070925
GeneOntologyBiologicalProcess	protein localization to cell-cell junction	TJP2 ACTN4 VCL	1.68e-04	24	93	3	GO:0150105
GeneOntologyBiologicalProcess	dendritic spine organization	SHANK1 KALRN ZMYND8 LRRK2 AFDN	1.74e-04	115	93	5	GO:0097061
GeneOntologyBiologicalProcess	neuron projection development	SHANK1 KLK6 BCL11B ATP7A RAPH1 TRIO KALRN USP9X ZMYND8 LRRK2 AFDN DMD ECE1 PREX1 MYO16 VCL	1.88e-04	1285	93	16	GO:0031175
GeneOntologyBiologicalProcess	regulation of postsynapse organization	KALRN USP9X ZMYND8 LRRK2 DGKB AFDN	1.92e-04	185	93	6	GO:0099175
GeneOntologyBiologicalProcess	modulation of excitatory postsynaptic potential	SHANK1 ZMYND8 LRRK2 AFDN	2.12e-04	65	93	4	GO:0098815
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	AKAP4 ATP7A USP9X IFT172 CEP250 DNAH17 SYNE2 ZMYND8 IFT80 VCL BBOF1	2.13e-04	670	93	11	GO:0120031
GeneOntologyBiologicalProcess	cytoplasmic microtubule organization	CCDC88C KATNAL2 IFT172 DYNC1H1	2.25e-04	66	93	4	GO:0031122
GeneOntologyBiologicalProcess	head development	AARS1 PTCHD1 BCL11B ATP7A CENPF USP9X IFT172 SYNE2 LRRK2 SEC16A AFDN MYO16 PHLPP2	2.39e-04	919	93	13	GO:0060322
GeneOntologyBiologicalProcess	cell projection assembly	AKAP4 ATP7A USP9X IFT172 CEP250 DNAH17 SYNE2 ZMYND8 IFT80 VCL BBOF1	2.57e-04	685	93	11	GO:0030031
GeneOntologyBiologicalProcess	transport along microtubule	ARL8B IFT172 SYNE2 ARL8A IFT80 DYNC1H1	2.69e-04	197	93	6	GO:0010970
GeneOntologyBiologicalProcess	neuron projection organization	SHANK1 KALRN ZMYND8 LRRK2 AFDN	2.76e-04	127	93	5	GO:0106027
GeneOntologyBiologicalProcess	positive regulation of dendritic spine development	SHANK1 KALRN ZMYND8 AFDN	2.83e-04	70	93	4	GO:0060999
GeneOntologyBiologicalProcess	cilium organization	CCDC88C AKAP4 USP9X IFT172 CEP250 DNAH17 SYNE2 IFT80 BBOF1	2.98e-04	476	93	9	GO:0044782
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	CCDC88C KATNAL2 IFT172 CEP250 DNAH17 SYNE2 CCDC78 NINL ZW10 DYNC1H1 BBOF1	3.93e-04	720	93	11	GO:0000226
GeneOntologyBiologicalProcess	dendritic spine development	SHANK1 KALRN ZMYND8 LRRK2 AFDN	4.46e-04	141	93	5	GO:0060996
GeneOntologyBiologicalProcess	endothelial cell development	TJP2 AFDN DMD VCL	4.71e-04	80	93	4	GO:0001885
GeneOntologyBiologicalProcess	dendritic spine morphogenesis	SHANK1 KALRN LRRK2 AFDN	4.94e-04	81	93	4	GO:0060997
GeneOntologyBiologicalProcess	postsynapse organization	SHANK1 KALRN USP9X ZMYND8 LRRK2 DGKB AFDN	5.38e-04	313	93	7	GO:0099173
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	SHANK1 BCL11B ATP7A RAPH1 TRIO KALRN USP9X LRRK2 AFDN ECE1 VCL	5.41e-04	748	93	11	GO:0048667
GeneOntologyBiologicalProcess	habituation	SHANK1 KALRN	5.53e-04	8	93	2	GO:0046959
GeneOntologyCellularComponent	perinuclear region of cytoplasm	AKAP4 ATP7A KALRN CENPF ENPP3 ASL CEP250 VPS50 CCDC78 SEC16A ACTN4 DMD CDC5L ECE1 TF PREX1 MYO16 RYR3	1.56e-07	934	94	18	GO:0048471
GeneOntologyCellularComponent	Z disc	AKAP4 CFL2 SYNE2 ACTN4 DMD VCL RYR3	5.40e-06	151	94	7	GO:0030018
GeneOntologyCellularComponent	I band	AKAP4 CFL2 SYNE2 ACTN4 DMD VCL RYR3	1.01e-05	166	94	7	GO:0031674
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	CENPF ARL8B IFT172 DNAH17 LRRK2 ARL8A DYNC1H1 BBOF1 BRWD1	1.30e-05	317	94	9	GO:0032838
GeneOntologyCellularComponent	cytoplasmic region	CENPF ARL8B IFT172 DNAH17 LRRK2 ARL8A DYNC1H1 BBOF1 BRWD1	3.54e-05	360	94	9	GO:0099568
GeneOntologyCellularComponent	microtubule organizing center	CCDC88C KATNAL2 TRAF5 CENPF USP9X IFT172 CEP250 CCDC78 NINL IFT80 DCLRE1B HERC2 DYNC1H1 BBOF1	6.01e-05	919	94	14	GO:0005815
GeneOntologyCellularComponent	sarcomere	AKAP4 CFL2 SYNE2 ACTN4 DMD VCL RYR3	1.33e-04	249	94	7	GO:0030017
GeneOntologyCellularComponent	myofibril	AKAP4 CFL2 SYNE2 ACTN4 DMD VCL RYR3	2.33e-04	273	94	7	GO:0030016
GeneOntologyCellularComponent	actin-based cell projection	ATP7A MYO1E RAPH1 SYNE2 LRRK2 DMD DYNC1H1	2.61e-04	278	94	7	GO:0098858
GeneOntologyCellularComponent	contractile muscle fiber	AKAP4 CFL2 SYNE2 ACTN4 DMD VCL RYR3	3.36e-04	290	94	7	GO:0043292
GeneOntologyCellularComponent	endoplasmic reticulum exit site	MIA3 LRRK2 SEC16A	8.90e-04	42	94	3	GO:0070971
GeneOntologyCellularComponent	somatodendritic compartment	SHANK1 ATP7A HTR2B KALRN CYP17A1 ASL ZMYND8 LRRK2 AFDN DMD TF PREX1 AR DYNC1H1	1.15e-03	1228	94	14	GO:0036477
GeneOntologyCellularComponent	neuron projection cytoplasm	ARL8B LRRK2 ARL8A DYNC1H1	1.54e-03	110	94	4	GO:0120111
GeneOntologyCellularComponent	ciliary basal body	CENPF IFT172 CEP250 IFT80 BBOF1	1.88e-03	195	94	5	GO:0036064
GeneOntologyCellularComponent	postsynapse	SHANK1 ATP7A TRIO KALRN USP9X SPTB ZMYND8 LRRK2 DGKB AFDN ACTN4 DMD	2.01e-03	1018	94	12	GO:0098794
GeneOntologyCellularComponent	axon	ATP7A ARL8B USP9X CYP17A1 LRRK2 AFDN ARL8A DMD PREX1 AR DYNC1H1	2.17e-03	891	94	11	GO:0030424
GeneOntologyCellularComponent	filopodium	RAPH1 SYNE2 DMD DYNC1H1	2.31e-03	123	94	4	GO:0030175
GeneOntologyCellularComponent	axoneme	CENPF IFT172 DNAH17 BBOF1 BRWD1	2.44e-03	207	94	5	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	CENPF IFT172 DNAH17 BBOF1 BRWD1	2.49e-03	208	94	5	GO:0097014
Domain	Spectrin	TRIO KALRN SPTB SYNE2 ACTN4 DMD	1.14e-09	23	92	6	PF00435
Domain	Spectrin_repeat	TRIO KALRN SPTB SYNE2 ACTN4 DMD	5.25e-09	29	92	6	IPR002017
Domain	SPEC	TRIO KALRN SPTB SYNE2 ACTN4 DMD	9.90e-09	32	92	6	SM00150
Domain	Spectrin/alpha-actinin	TRIO KALRN SPTB SYNE2 ACTN4 DMD	9.90e-09	32	92	6	IPR018159
Domain	ACTININ_2	SPTB SYNE2 ACTN4 DMD	4.54e-06	23	92	4	PS00020
Domain	ACTININ_1	SPTB SYNE2 ACTN4 DMD	4.54e-06	23	92	4	PS00019
Domain	Actinin_actin-bd_CS	SPTB SYNE2 ACTN4 DMD	4.54e-06	23	92	4	IPR001589
Domain	SH3	SHANK1 MIA3 MYO1E TRIO KALRN CASKIN2 TJP2	9.57e-05	216	92	7	SM00326
Domain	SH3	SHANK1 MIA3 MYO1E TRIO KALRN CASKIN2 TJP2	9.57e-05	216	92	7	PS50002
Domain	SH3_domain	SHANK1 MIA3 MYO1E TRIO KALRN CASKIN2 TJP2	1.07e-04	220	92	7	IPR001452
Domain	CRAL_TRIO	PRUNE2 TRIO KALRN	1.44e-04	21	92	3	PF00650
Domain	-	PRUNE2 TRIO KALRN	1.91e-04	23	92	3	3.40.525.10
Domain	Glyco_hydro_38_C	MAN2A2 MAN2A1	2.38e-04	5	92	2	IPR011682
Domain	Alpha-mann_mid	MAN2A2 MAN2A1	2.38e-04	5	92	2	PF09261
Domain	Glyco_hydro_57/38_cen	MAN2A2 MAN2A1	2.38e-04	5	92	2	IPR028995
Domain	Glyco_hydro_38	MAN2A2 MAN2A1	2.38e-04	5	92	2	PF01074
Domain	-	MAN2A2 MAN2A1	2.38e-04	5	92	2	1.20.1270.50
Domain	-	MAN2A2 MAN2A1	2.38e-04	5	92	2	3.20.110.10
Domain	Alpha-mann_mid	MAN2A2 MAN2A1	2.38e-04	5	92	2	SM00872
Domain	Glyco_hydro_38_N	MAN2A2 MAN2A1	2.38e-04	5	92	2	IPR000602
Domain	Glyco_hydro_38/57_N	MAN2A2 MAN2A1	2.38e-04	5	92	2	IPR027291
Domain	Glyco_hydro_38_cen	MAN2A2 MAN2A1	2.38e-04	5	92	2	IPR015341
Domain	Glyco_hydro_38C	MAN2A2 MAN2A1	2.38e-04	5	92	2	PF07748
Domain	SEC14	PRUNE2 TRIO KALRN	2.46e-04	25	92	3	SM00516
Domain	CH	SPTB SYNE2 ACTN4 DMD	2.97e-04	65	92	4	SM00033
Domain	CRAL_TRIO	PRUNE2 TRIO KALRN	3.11e-04	27	92	3	PS50191
Domain	CRAL-TRIO_dom	PRUNE2 TRIO KALRN	3.47e-04	28	92	3	IPR001251
Domain	CH	SPTB SYNE2 ACTN4 DMD	3.94e-04	70	92	4	PF00307
Domain	-	TRIO KALRN ALS2CL PREX1	4.16e-04	71	92	4	1.20.900.10
Domain	DH-domain	TRIO KALRN ALS2CL PREX1	4.16e-04	71	92	4	IPR000219
Domain	-	SPTB SYNE2 ACTN4 DMD	4.16e-04	71	92	4	1.10.418.10
Domain	CH	SPTB SYNE2 ACTN4 DMD	4.63e-04	73	92	4	PS50021
Domain	Glyco_hydro/deAcase_b/a-brl	MAN2A2 MAN2A1	4.96e-04	7	92	2	IPR011330
Domain	E-NPP	ENPP3 ENPP5	4.96e-04	7	92	2	IPR024873
Domain	CH-domain	SPTB SYNE2 ACTN4 DMD	5.13e-04	75	92	4	IPR001715
Domain	SH3_2	SHANK1 MIA3 CASKIN2 TJP2	8.60e-04	86	92	4	PF07653
Domain	SH3_2	SHANK1 MIA3 CASKIN2 TJP2	8.60e-04	86	92	4	IPR011511
Domain	Phosphodiest/P_Trfase	ENPP3 ENPP5	1.05e-03	10	92	2	IPR002591
Domain	Phosphodiest	ENPP3 ENPP5	1.05e-03	10	92	2	PF01663
Domain	-	SHANK1 PIK3AP1 CASKIN2 LRRK2 KANK4 MYO16	1.42e-03	248	92	6	1.25.40.20
Domain	Ankyrin_rpt-contain_dom	SHANK1 PIK3AP1 CASKIN2 LRRK2 KANK4 MYO16	1.60e-03	254	92	6	IPR020683
Domain	-	NINL DGKB ACTN4 DMD LETM1 RYR3	1.84e-03	261	92	6	1.10.238.10
Domain	Ankyrin_rpt	SHANK1 RAPH1 CASKIN2 LRRK2 KANK4 MYO16	1.87e-03	262	92	6	IPR002110
Domain	-	MAN2A2 MAN2A1	2.10e-03	14	92	2	2.60.40.1180
Domain	WD40_repeat	IFT172 LRRK2 ELP2 IFT80 HERC2 BRWD1	2.26e-03	272	92	6	IPR001680
Domain	Glyco_hydro_b	MAN2A2 MAN2A1	2.42e-03	15	92	2	IPR013780
Domain	EF-hand-dom_pair	NINL DGKB ACTN4 DMD LETM1 RYR3	2.95e-03	287	92	6	IPR011992
Domain	Gal_mutarotase_SF_dom	MAN2A2 MAN2A1	3.11e-03	17	92	2	IPR011013
Domain	Rib_L2_dom2	HERC2 UHRF2	3.49e-03	18	92	2	IPR014722
Domain	ZF_ZZ_2	HERC2 DMD	3.49e-03	18	92	2	PS50135
Domain	ZF_ZZ_1	HERC2 DMD	3.49e-03	18	92	2	PS01357
Domain	ZZ	HERC2 DMD	3.49e-03	18	92	2	PF00569
Domain	-	HERC2 UHRF2	3.49e-03	18	92	2	2.30.30.30
Domain	DH_1	TRIO KALRN PREX1	3.71e-03	63	92	3	PS00741
Domain	Znf_ZZ	HERC2 DMD	3.89e-03	19	92	2	IPR000433
Domain	ZnF_ZZ	HERC2 DMD	3.89e-03	19	92	2	SM00291
Domain	RhoGEF	TRIO KALRN PREX1	4.60e-03	68	92	3	SM00325
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	STARD13 TRIO KALRN CENPF USP9X SYDE2 KTN1 TJP2 ZW10 PREX1 AR DYNC1H1 LETM1	2.90e-05	649	74	13	MM15690
Pathway	REACTOME_RHOG_GTPASE_CYCLE	TRIO KALRN KTN1 PREX1 LETM1	3.46e-05	71	74	5	MM15604
Pathway	REACTOME_RHOG_GTPASE_CYCLE	TRIO KALRN KTN1 PREX1 LETM1	4.22e-05	74	74	5	M41814
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	STARD13 TRIO KALRN CENPF USP9X SYDE2 KTN1 TJP2 ZW10 PREX1 AR DYNC1H1 LETM1	8.42e-05	720	74	13	M41838
Pathway	REACTOME_RHOA_GTPASE_CYCLE	STARD13 TRIO KALRN KTN1 TJP2 PREX1	9.92e-05	142	74	6	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	STARD13 TRIO KALRN KTN1 TJP2 PREX1	1.29e-04	149	74	6	M41805
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	MIA3 MAN2A2 MAN2A1 SPTB SEC16A DYNC1H1	4.41e-04	187	74	6	M961
Pathway	REACTOME_RHO_GTPASE_CYCLE	STARD13 TRIO KALRN USP9X SYDE2 KTN1 TJP2 PREX1 LETM1	4.66e-04	439	74	9	MM15595
Pathway	KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE	CENPF ZW10 DYNC1H1	5.09e-04	30	74	3	M47889
Pathway	REACTOME_RHO_GTPASE_CYCLE	STARD13 TRIO KALRN USP9X SYDE2 KTN1 TJP2 PREX1 LETM1	5.58e-04	450	74	9	M27078
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	MIA3 MAN2A2 MAN2A1 SPTB SEC16A DYNC1H1	6.63e-04	202	74	6	MM15650
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PIK3AP1 CCDC88C MIA3 RAPH1 TRIO CEP250 PHACTR4 NINL TJP2 AFDN ACTN4 HERC2 ECE1 PPP6R2 PCCA LRP1B DYNC1H1 VCL BRWD1	1.33e-12	853	94	19	28718761
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SHANK1 AARS1 MYO1E TRIO KALRN RBL2 CTR9 USP9X IFT172 SPTB ZMYND8 ENPP5 AFDN ACTN4 HERC2 LRP1B TF PREX1 CNOT3 DYNC1H1 RYR3 BRWD1	3.20e-12	1285	94	22	35914814
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 MYO1E RNPEP TRIO KALRN USP9X CFL2 SPTB KTN1 SEC16A TJP2 DGKB AFDN ACTN4 DMD CDC5L PPP6R2 TF DYNC1H1 LETM1 VCL PDXK	2.58e-11	1431	94	22	37142655
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHANK1 CCDC88C MIA3 BCL11B TRIO KALRN CENPF USP9X KTN1 SYNE2 SEC16A AFDN HERC2 CDC5L PPP6R2 JAKMIP2 DYNC1H1 LETM1	9.75e-11	963	94	18	28671696
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MAN2A1 RNPEP KALRN ARL8B RBL2 ENPP3 ASL CEP250 VPS50 LRRK2 ARL8A PKD1L3 ECE1 TF DYNC1H1 VCL PDXK	1.83e-09	1016	94	17	19056867
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MIA3 RAPH1 TRIO CASKIN2 CTR9 USP9X SYNE2 SEC16A ACTN4 ELP2 HERC2 DMD CDC5L PPP6R2 LETM1 PHLPP2 TTC33	2.96e-09	1049	94	17	27880917
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	SHANK1 CCDC88C AARS1 BCL11B TRIO IFT172 SMCHD1 LRRK2 ACTN4 HERC2 CDC5L TTC33	1.49e-08	513	94	12	25798074
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	AARS1 RNPEP CENPF USP9X SMCHD1 SYNE2 SEC16A TJP2 AFDN ACTN4 HERC2 DYNC1H1 VCL	2.40e-08	653	94	13	22586326
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	AARS1 TRIO CENPF USP9X ZMYND8 SEC16A ACTN4 DYNC1H1 LETM1 PDXK	2.44e-08	332	94	10	37433992
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPH1 USP9X SMCHD1 KTN1 PHACTR4 SEC16A TJP2 AFDN CDC5L PCCA DYNC1H1 VCL	3.14e-08	549	94	12	38280479
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	STARD13 AARS1 MYO1E ARL8B CTR9 IFT172 KTN1 VPS50 SEC16A NINL AFDN ACTN4 IFT80 ZW10 TF DYNC1H1 VCL	8.54e-08	1321	94	17	27173435
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	MIA3 USP9X KTN1 SEC16A ACTN4 CDC5L PPP6R2 DYNC1H1 VCL BRWD1	1.36e-07	399	94	10	37536630
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SHANK1 MIA3 TRIO KALRN USP9X KTN1 TJP2 AFDN ACTN4 ARL8A PPP6R2 PCCA LRP1B CNOT3 PDXK	4.04e-07	1139	94	15	36417873
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	TRIO CENPF HERC2 DMD CDC5L DYNC1H1	9.45e-07	120	94	6	31413325
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	AARS1 HTR2B CENPF USP9X KTN1 VPS50 ZMYND8 TJP2 TGM5 RYR3	1.00e-06	497	94	10	36774506
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	AARS1 RNPEP TRIO CENPF CTR9 USP9X SMCHD1 KTN1 AFDN ACTN4 ARL8A CDC5L DYNC1H1 LETM1 VCL PDXK	1.30e-06	1425	94	16	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 RAPH1 CENPF ARL8B CTR9 CFL2 SMCHD1 KTN1 SYNE2 ACTN4 ARL8A DMD ECE1 PREX1 LETM1 BBOF1	1.52e-06	1442	94	16	35575683
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	AARS1 CTR9 IFT172 SMCHD1 SEC16A TJP2 AFDN ACTN4 DMD CDC5L PPP6R2 TF VCL	2.23e-06	974	94	13	28675297
Pubmed	KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle.	USP9X SEC16A PPP6R2	2.26e-06	10	94	3	36995092
Pubmed	Genetic and molecular evidence of an X-chromosome deletion spanning the tabby (Ta) and testicular feminization (Tfm) loci in the mouse.	ATP7A DMD AR	2.26e-06	10	94	3	2055107
Pubmed	Defining the membrane proteome of NK cells.	AARS1 MIA3 ATP7A MAN2A1 ARL8B USP9X KTN1 VPS50 ARL8A HERC2 CDC5L ZW10 ECE1 DYNC1H1	3.07e-06	1168	94	14	19946888
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CCDC88C MIA3 USP9X SEC16A NINL TJP2 AFDN PPP6R2 LETM1	3.51e-06	446	94	9	24255178
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	TRIO KALRN CENPF DMD CDC5L DYNC1H1	3.60e-06	151	94	6	17043677
Pubmed	Conservation and reorganization of loci on the mammalian X chromosome: a molecular framework for the identification of homologous subchromosomal regions in man and mouse.	ATP7A DMD AR	4.13e-06	12	94	3	2899541
Pubmed	Functional proteomics mapping of a human signaling pathway.	STARD13 RNPEP CTR9 CEP250 ZMYND8 AFDN HERC2 UHRF2 DYNC1H1 VCL	4.68e-06	591	94	10	15231748
Pubmed	RAB-like 2 has an essential role in male fertility, sperm intra-flagellar transport, and tail assembly.	AARS1 IFT172 ACTN4 TF VCL	5.29e-06	92	94	5	23055941
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	SYNE2 PHACTR4 HERC2 CDC5L BRWD1	5.29e-06	92	94	5	15840729
Pubmed	The murine interleukin-2 receptor gamma chain gene: organization, chromosomal localization and expression in the adult thymus.	ATP7A DMD AR	5.36e-06	13	94	3	7805729
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	TRIO KALRN USP9X IFT172 SMCHD1 KANK4 HERC2 CDC5L TF	5.84e-06	475	94	9	31040226
Pubmed	Drosophila Topors is a RING finger-containing protein that functions as a ubiquitin-protein isopeptide ligase for the hairy basic helix-loop-helix repressor protein.	ARL8B ARL8A	7.23e-06	2	94	2	14871887
Pubmed	TRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration.	TRPM8 AR	7.23e-06	2	94	2	31501416
Pubmed	Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells.	CYP17A1 AR	7.23e-06	2	94	2	22174412
Pubmed	Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme.	MAN2A2 MAN2A1	7.23e-06	2	94	2	8524845
Pubmed	Immunohistochemical localization of androgen receptors in testicular cells of mice with mosaic mutation.	ATP7A AR	7.23e-06	2	94	2	12056625
Pubmed	An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility.	ARL8B ARL8A	7.23e-06	2	94	2	16537643
Pubmed	Presynaptic Biogenesis Requires Axonal Transport of Lysosome-Related Vesicles.	ARL8B ARL8A	7.23e-06	2	94	2	30174114
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	7.23e-06	2	94	2	26858404
Pubmed	Essential and mutually compensatory roles of {alpha}-mannosidase II and {alpha}-mannosidase IIx in N-glycan processing in vivo in mice.	MAN2A2 MAN2A1	7.23e-06	2	94	2	16754854
Pubmed	A close correlation in the expression patterns of Af-6 and Usp9x in Sertoli and granulosa cells of mouse testis and ovary.	USP9X AFDN	7.23e-06	2	94	2	15509704
Pubmed	[Vinculin and the androgen receptor in prostate cancer: expressions and correlations].	AR VCL	7.23e-06	2	94	2	21171262
Pubmed	A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer.	CYP17A1 AR	7.23e-06	2	94	2	28036278
Pubmed	The Ras target AF-6 is a substrate of the fam deubiquitinating enzyme.	USP9X AFDN	7.23e-06	2	94	2	9722616
Pubmed	Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.	CYP17A1 AR	7.23e-06	2	94	2	21868758
Pubmed	N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay.	MAN2A2 MAN2A1	7.23e-06	2	94	2	17113875
Pubmed	Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.	CYP17A1 AR	7.23e-06	2	94	2	25897673
Pubmed	Germ cell survival through carbohydrate-mediated interaction with Sertoli cells.	MAN2A2 MAN2A1	7.23e-06	2	94	2	11778047
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLIN4 PRUNE2 CCDC88C KTN1 DNAH17 CDC5L PPP6R2 PREX1 CNOT3	7.87e-06	493	94	9	15368895
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRUNE2 AARS1 MYO1E CTR9 USP9X ASL KTN1 PHACTR4 SEC16A TJP2 ACTN4 ELP2 ZW10 DYNC1H1 VCL	8.14e-06	1455	94	15	22863883
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ATP7A ARL8B SYDE2 PHACTR4 LRRK2 SEC16A TJP2 AFDN ARL8A PCCA DYNC1H1	8.27e-06	777	94	11	35844135
Pubmed	IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration.	USP9X ELP2 DYNC1H1	8.50e-06	15	94	3	18303054
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	RBL2 USP9X KTN1 ACTN4 LETM1 VCL	9.56e-06	179	94	6	36261009
Pubmed	CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.	SYNE2 CDC5L TF	1.51e-05	18	94	3	33361760
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	AARS1 TRIO ACTN4 DMD DYNC1H1 LETM1 VCL	1.71e-05	298	94	7	30737378
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	KALRN CENPF CFL2 SEC16A AFDN DMD VCL	1.94e-05	304	94	7	32235678
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CCDC88C AARS1 RAPH1 TRIO CASKIN2 SYDE2 SYNE2 PHACTR4 SEC16A TJP2 AFDN	2.14e-05	861	94	11	36931259
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	RNPEP CTR9 VPS50 ZMYND8 AFDN ELP2 CNOT3 DYNC1H1 LETM1	2.16e-05	560	94	9	35241646
Pubmed	The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin.	USP9X AFDN	2.16e-05	3	94	2	10620020
Pubmed	Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action.	TRIO KALRN	2.16e-05	3	94	2	31801062
Pubmed	Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms.	CYP17A1 AR	2.16e-05	3	94	2	17669147
Pubmed	[A case-control study of environmental and genetic factors and prostate cancer in Guangdong].	CYP17A1 AR	2.16e-05	3	94	2	19954068
Pubmed	Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells.	TF VCL	2.16e-05	3	94	2	19951918
Pubmed	Co-localization of FAM and AF-6, the mammalian homologues of Drosophila faf and canoe, in mouse eye development.	USP9X AFDN	2.16e-05	3	94	2	10704870
Pubmed	Allelic frequencies of six polymorphic markers for risk of prostate cancer.	CYP17A1 AR	2.16e-05	3	94	2	11847524
Pubmed	Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo.	DMD VCL	2.16e-05	3	94	2	15128702
Pubmed	Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S.	CFL2 LRRK2	2.16e-05	3	94	2	20130188
Pubmed	Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.	CYP17A1 AR	2.16e-05	3	94	2	18601603
Pubmed	Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.	AR VCL	2.16e-05	3	94	2	22309306
Pubmed	Ponsin/SH3P12: an l-afadin- and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions.	AFDN VCL	2.16e-05	3	94	2	10085297
Pubmed	Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity.	TRPM8 AR	2.16e-05	3	94	2	32277850
Pubmed	X-linked gene for testicular feminization in the mouse.	ATP7A AR	2.16e-05	3	94	2	5452809
Pubmed	Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.	CYP17A1 AR	2.16e-05	3	94	2	17108148
Pubmed	Aciculin and its relation to dystrophin: immunocytochemical studies in human normal and Duchenne dystrophy quadriceps muscles.	SPTB DMD	2.16e-05	3	94	2	10867799
Pubmed	Inherited variation in hormone-regulating genes and prostate cancer survival.	CYP17A1 AR	2.16e-05	3	94	2	17785571
Pubmed	Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton.	DMD VCL	2.16e-05	3	94	2	12711699
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	AARS1 MYO1E ARL8B KTN1 SEC16A ACTN4 DYNC1H1	2.30e-05	312	94	7	37120454
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	AARS1 MYO1E RAPH1 RNPEP CTR9 USP9X SMCHD1 KTN1 SYNE2 SEC16A ACTN4 CDC5L DYNC1H1 LETM1	2.65e-05	1415	94	14	28515276
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PIK3AP1 AARS1 MIA3 TRIO KTN1 VPS50 SEC16A TJP2 CDC5L VCL	2.99e-05	733	94	10	34672954
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	AARS1 USP9X ASL ACTN4 DYNC1H1 VCL PDXK	4.27e-05	344	94	7	30333137
Pubmed	PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.	CYP17A1 AR	4.32e-05	4	94	2	18491956
Pubmed	Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.	CYP17A1 AR	4.32e-05	4	94	2	11571725
Pubmed	[Genetic determinants of anatomical variants of the prostate].	CYP17A1 AR	4.32e-05	4	94	2	18501301
Pubmed	Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways.	CYP17A1 AR	4.32e-05	4	94	2	20628746
Pubmed	Novel small GTPase subfamily capable of associating with tubulin is required for chromosome segregation.	ARL8B ARL8A	4.32e-05	4	94	2	15331635
Pubmed	Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.	CYP17A1 AR	4.32e-05	4	94	2	12370109
Pubmed	Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.	CYP17A1 AR	4.32e-05	4	94	2	18495332
Pubmed	Association between hormonal genetic polymorphisms and early-onset prostate cancer.	CYP17A1 AR	4.32e-05	4	94	2	15711606
Pubmed	Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.	LRRK2 SEC16A	4.32e-05	4	94	2	25201882
Pubmed	Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin.	TJP2 AFDN	4.32e-05	4	94	2	10613913
Pubmed	LEK1 is a potential inhibitor of pocket protein-mediated cellular processes.	CENPF RBL2	4.32e-05	4	94	2	14555653
Pubmed	Structural dynamics of alpha-actinin-vinculin interactions.	ACTN4 VCL	4.32e-05	4	94	2	15988023
Pubmed	Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus.	TRPM8 ECE1	4.32e-05	4	94	2	24812665
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CCDC88C MAN2A2 MYO1E TRIO KALRN SEC16A NINL CARD10 HERC2 ECE1 PREX1 DYNC1H1	4.33e-05	1105	94	12	35748872
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MIA3 ATP7A CASKIN2 CTR9 KTN1 SYNE2 PHACTR4 ELP2 IFT80 HERC2 CDC5L PPP6R2 LETM1 VCL	4.55e-05	1487	94	14	33957083
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	AARS1 MIA3 MAN2A1 RNPEP TRIO SMCHD1 SYNE2 ACTN4 ARL8A ECE1 CNOT3 DYNC1H1 PDXK	4.64e-05	1297	94	13	33545068
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	ARL8B USP9X SMCHD1 KTN1 ACTN4 PCCA DYNC1H1 VCL	5.19e-05	484	94	8	31995728
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	MIA3 SPTB KTN1 SEC16A TJP2 CDC5L DYNC1H1	5.68e-05	360	94	7	33111431
Pubmed	PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.	RNPEP USP9X SEC16A HERC2 PPP6R2 VCL	5.83e-05	247	94	6	32989298
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MAN2A2 TRIO KALRN SPTB KTN1 SYNE2 ACTN4 VCL	6.25e-05	497	94	8	23414517
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	RAPH1 CENPF USP9X SMCHD1 KTN1 SYNE2 VPS50 SEC16A	6.33e-05	498	94	8	36634849
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	STARD13 AARS1 MIA3 ARL8B KTN1 ACTN4 PCCA DYNC1H1 MYO16 VCL	6.69e-05	807	94	10	30575818
Interaction	KCTD13 interactions	SHANK1 MYO1E RNPEP TRIO KALRN USP9X CFL2 SPTB KTN1 SEC16A TJP2 DGKB AFDN ACTN4 DMD CDC5L PPP6R2 TF DYNC1H1 LETM1 VCL PDXK	3.23e-07	1394	94	22	int:KCTD13
Interaction	CTNNA1 interactions	TDRD7 CCDC88C CENPF PHACTR4 TJP2 AFDN HERC2 DMD CDC5L AR VCL	6.50e-07	347	94	11	int:CTNNA1
Interaction	MEX3A interactions	AARS1 TRIO CENPF USP9X ZMYND8 SEC16A ACTN4 CNOT3 DYNC1H1 LETM1 PDXK	1.75e-06	384	94	11	int:MEX3A
Interaction	DNMBP interactions	RAPH1 SYNE2 NINL TJP2 AFDN PREX1 VCL	1.85e-06	124	94	7	int:DNMBP
Interaction	YWHAG interactions	CCDC88C AARS1 RAPH1 ARL8B CASKIN2 SYDE2 CEP250 SYNE2 PHACTR4 LRRK2 SEC16A NINL TJP2 AFDN ACTN4 ARL8A CDC5L DYNC1H1 VCL	4.07e-06	1248	94	19	int:YWHAG
Interaction	CAPZA2 interactions	MYO1E CFL2 KTN1 LRRK2 SEC16A NINL AFDN CARD10 ACTN4 AR CNOT3	5.17e-06	430	94	11	int:CAPZA2
Interaction	LATS2 interactions	CCDC88C MIA3 USP9X SEC16A NINL TJP2 AFDN AR LETM1	8.30e-06	289	94	9	int:LATS2
Interaction	TNIK interactions	SHANK1 BCL11B TRIO KALRN CENPF USP9X SYNE2 HERC2 CDC5L DYNC1H1	1.14e-05	381	94	10	int:TNIK
Interaction	NDEL1 interactions	KALRN CENPF CTR9 KTN1 NINL DYNC1H1 VCL	1.17e-05	164	94	7	int:NDEL1
Interaction	NEK4 interactions	SHANK1 CCDC88C AARS1 BCL11B TRIO IFT172 SMCHD1 LRRK2 ACTN4 HERC2 CDC5L TTC33	1.66e-05	582	94	12	int:NEK4
Interaction	GJA1 interactions	AARS1 MIA3 ATP7A TRIO KALRN CASKIN2 USP9X KTN1 SYNE2 PHACTR4 SEC16A TJP2	1.69e-05	583	94	12	int:GJA1
Interaction	PFN1 interactions	RAPH1 TRIO CFL2 KTN1 SYNE2 SEC16A TJP2 AFDN PPP6R2 AR VCL	2.50e-05	509	94	11	int:PFN1
Interaction	MAPRE1 interactions	MYO1E RAPH1 TRIO ARL8B CEP250 KTN1 LRRK2 SEC16A ACTN4 HERC2 DYNC1H1	2.73e-05	514	94	11	int:MAPRE1
Interaction	NCK2 interactions	PIK3AP1 SPATA2L MIA3 RAPH1 CASKIN2 SYNE2 TJP2 AFDN	3.11e-05	262	94	8	int:NCK2
Interaction	RAVER1 interactions	CEP250 NINL ACTN4 CDC5L AR CNOT3 VCL	3.47e-05	194	94	7	int:RAVER1
Interaction	SIRT7 interactions	AARS1 RNPEP CENPF USP9X SMCHD1 SYNE2 SEC16A TJP2 AFDN ACTN4 HERC2 DYNC1H1 VCL	4.08e-05	744	94	13	int:SIRT7
Interaction	CLASP1 interactions	ARL8A CDC5L ZW10 JAKMIP2 DYNC1H1 VCL	4.59e-05	138	94	6	int:CLASP1
Interaction	YWHAH interactions	CCDC88C MYO1E RNPEP TRIO ARL8B CASKIN2 SYDE2 SYNE2 PHACTR4 LRRK2 SEC16A NINL TJP2 AFDN ARL8A VCL	4.67e-05	1102	94	16	int:YWHAH
Interaction	DYRK1A interactions	MYO1E CENPF RBL2 CFL2 SEC16A NINL TJP2 ELP2 LRP1B CNOT3 PDXK	5.22e-05	552	94	11	int:DYRK1A
Interaction	TDRD3 interactions	TDRD7 MIA3 USP9X SEC16A NINL TJP2 CNOT3	6.09e-05	212	94	7	int:TDRD3
Interaction	DYNC1LI2 interactions	PRUNE2 ARL8B PHACTR4 NINL CDC5L DYNC1H1	8.45e-05	154	94	6	int:DYNC1LI2
Interaction	FAM167A interactions	MIA3 CENPF CEP250 KTN1 CARD10	8.67e-05	96	94	5	int:FAM167A
Interaction	TRAF3IP1 interactions	IFT172 ACTN4 IFT80 DMD CDC5L	8.67e-05	96	94	5	int:TRAF3IP1
Interaction	RAB5A interactions	CCDC88C MIA3 KTN1 SYNE2 PHACTR4 LRRK2 SEC16A HERC2 ECE1 ALS2CL TF DYNC1H1	1.07e-04	706	94	12	int:RAB5A
Interaction	EED interactions	AARS1 MAN2A1 MYO1E RNPEP TRIO ARL8B TRIM35 USP9X SMCHD1 TJP2 AFDN ACTN4 HERC2 CDC5L ZW10 UHRF2 AR DYNC1H1	1.08e-04	1445	94	18	int:EED
Interaction	LYN interactions	PIK3AP1 PRUNE2 CCDC88C ATP7A MYO1E TRIO CASKIN2 PHACTR4 AFDN DMD UHRF2 AR	1.29e-04	720	94	12	int:LYN
Interaction	STK24 interactions	ZNF569 VPS50 LRRK2 TJP2 CDC5L VCL	1.36e-04	168	94	6	int:STK24
Interaction	PAK4 interactions	USP9X TJP2 AFDN CDC5L DYNC1H1 VCL	1.41e-04	169	94	6	int:PAK4
Interaction	DBN1 interactions	MYO1E CFL2 LRRK2 SEC16A AFDN CARD10 ACTN4 HERC2 ECE1	1.44e-04	417	94	9	int:DBN1
Interaction	PPP1R13B interactions	CENPF CEP250 NINL TJP2 AFDN CDC5L	1.76e-04	176	94	6	int:PPP1R13B
Interaction	PRICKLE1 interactions	STARD13 USP9X SYNE2 DMD	1.77e-04	60	94	4	int:PRICKLE1
Interaction	LMO7 interactions	MYO1E ARL8B NINL TJP2 ACTN4 CDC5L	1.81e-04	177	94	6	int:LMO7
Interaction	YWHAQ interactions	CCDC88C ARL8B SYDE2 CEP250 SPTB PHACTR4 LRRK2 TJP2 AFDN ARL8A CDC5L AR DYNC1H1 VCL PDXK	1.98e-04	1118	94	15	int:YWHAQ
Interaction	PRICKLE2 interactions	STARD13 USP9X SYNE2 DMD	2.01e-04	62	94	4	int:PRICKLE2
Interaction	LPXN interactions	STARD13 SYNE2 DMD PREX1 VCL	2.03e-04	115	94	5	int:LPXN
Interaction	FBXO22 interactions	AARS1 HTR2B CENPF USP9X KTN1 VPS50 ZMYND8 TJP2 TGM5 RYR3	2.11e-04	540	94	10	int:FBXO22
Interaction	MATR3 interactions	HTR2B RAPH1 USP9X SMCHD1 CEP250 VPS50 TJP2 ELP2 HERC2 CDC5L AR	2.35e-04	655	94	11	int:MATR3
Interaction	CTNNB1 interactions	CCDC88C USP9X CEP250 SYNE2 LRRK2 SEC16A TJP2 AFDN ACTN4 HERC2 UHRF2 AR DYNC1H1 VCL	2.35e-04	1009	94	14	int:CTNNB1
Interaction	ARHGAP26 interactions	STARD13 CTR9 SYNE2 DMD MYO16	2.48e-04	120	94	5	int:ARHGAP26
Interaction	SORBS1 interactions	KALRN TJP2 AFDN HERC2 VCL	2.78e-04	123	94	5	int:SORBS1
Interaction	SYNPO interactions	MYO1E KALRN CFL2 SEC16A ACTN4 CDC5L	2.81e-04	192	94	6	int:SYNPO
Interaction	CEP135 interactions	CCDC88C SPATA2L MIA3 CEP250 SEC16A TJP2 HERC2	2.84e-04	272	94	7	int:CEP135
Interaction	ARHGAP12 interactions	RAPH1 KTN1 PHACTR4 TJP2	2.88e-04	68	94	4	int:ARHGAP12
Interaction	PDLIM5 interactions	STARD13 SYNE2 TJP2 DMD PREX1 DYNC1H1 VCL	2.91e-04	273	94	7	int:PDLIM5
Interaction	MARK2 interactions	ARL8B AFDN ARL8A HERC2 DMD CDC5L PPP6R2	2.97e-04	274	94	7	int:MARK2
Interaction	MOB3C interactions	MIA3 USP9X KTN1 SEC16A CDC5L PPP6R2 DYNC1H1 VCL	3.02e-04	364	94	8	int:MOB3C
Interaction	CCDC88C interactions	CCDC88C NINL AFDN DYNC1H1	3.40e-04	71	94	4	int:CCDC88C
Interaction	SSUH2 interactions	KLK6 ARL8B TJP2 AFDN CDC5L TF	3.40e-04	199	94	6	int:SSUH2
Interaction	CIT interactions	AARS1 MYO1E KALRN CENPF CTR9 CFL2 SMCHD1 SPTB KTN1 SYNE2 ZMYND8 LRRK2 TJP2 ACTN4 CDC5L UHRF2 DYNC1H1	3.54e-04	1450	94	17	int:CIT
Interaction	PAK6 interactions	USP9X LRRK2 AFDN AR	3.78e-04	73	94	4	int:PAK6
Interaction	CDC42 interactions	AARS1 MYO1E RAPH1 TRIO ARL8B USP9X CFL2 KTN1 SYNE2 PHACTR4 LRRK2 AFDN HERC2 CDC5L ZW10 PREX1	3.84e-04	1323	94	16	int:CDC42
Interaction	TPX2 interactions	MYO1E TJP2 CDC5L UHRF2 PREX1 AR	3.88e-04	204	94	6	int:TPX2
Interaction	DST interactions	CFL2 CEP250 KTN1 AFDN HERC2 CDC5L VCL	3.93e-04	287	94	7	int:DST
Interaction	LGALS9 interactions	ATP7A ARL8B USP9X SMCHD1 KTN1 ACTN4 ECE1 PCCA DYNC1H1 VCL	4.15e-04	588	94	10	int:LGALS9
Interaction	BIRC3 interactions	AARS1 RNPEP TRIO CENPF CTR9 USP9X SMCHD1 KTN1 AFDN ACTN4 ARL8A CDC5L DYNC1H1 LETM1 VCL PDXK	4.21e-04	1334	94	16	int:BIRC3
Interaction	SUMO2 interactions	AARS1 KALRN CTR9 USP9X SMCHD1 ZMYND8 LRRK2 UHRF2 AR DYNC1H1	4.32e-04	591	94	10	int:SUMO2
Interaction	KDM4C interactions	USP9X SMCHD1 ACTN4 AR	4.40e-04	76	94	4	int:KDM4C
Interaction	AGAP2 interactions	SHANK1 TRIO KALRN USP9X ACTN4 DYNC1H1	4.53e-04	210	94	6	int:AGAP2
Interaction	VASP interactions	RAPH1 CEP250 PHACTR4 SEC16A TJP2 ACTN4 VCL	4.54e-04	294	94	7	int:VASP
Interaction	RCOR1 interactions	RAPH1 CENPF VPS50 ZMYND8 SEC16A NINL UHRF2 PCCA AR	4.99e-04	494	94	9	int:RCOR1
Interaction	SHANK3 interactions	TDRD7 SHANK1 MAN2A2 KALRN KTN1 ACTN4 ARL8A PPP6R2 DYNC1H1	5.14e-04	496	94	9	int:SHANK3
GeneFamily	Mannosidases alpha class 2	MAN2A2 MAN2A1	1.51e-04	5	71	2	1194
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO KALRN PREX1	2.22e-03	66	71	3	722
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	HERC2 DMD	2.23e-03	18	71	2	91
GeneFamily	PDZ domain containing	SHANK1 TJP2 AFDN PREX1	3.01e-03	152	71	4	1220
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT172 IFT80	3.97e-03	24	71	2	615
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	TJP2 CARD10	4.65e-03	26	71	2	904
Coexpression	HALLMARK_MITOTIC_SPINDLE	MYO1E TRIO CENPF CEP250 ACTN4 ARL8A PREX1 DYNC1H1 VCL	4.26e-08	199	94	9	M5893
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TDRD7 STARD13 MAN2A1 TRIO CENPF USP9X SMCHD1 SYNE2 ZMYND8 TJP2 DMD PCCA VCL PHLPP2	2.18e-06	856	94	14	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TDRD7 STARD13 MAN2A1 TRIO CENPF USP9X SMCHD1 ZMYND8 TJP2 PHLPP2	6.83e-06	466	94	10	M13522
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP	TRAF5 TRIO RBL2 CARD10 CDC5L ECE1 CNOT3	7.66e-06	199	94	7	M5205
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	STARD13 PRUNE2 MAN2A1 RAPH1 TRIO ARL8B RBL2 CTR9 KANK4 HERC2 CDC5L ZW10 JAKMIP2 PREX1	1.42e-05	1009	94	14	M157
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	TDRD7 PIK3AP1 PRUNE2 CTR9 NINL XKR5	2.46e-05	160	94	6	M8664
Coexpression	MURARO_PANCREAS_BETA_CELL	PRUNE2 AARS1 MIA3 MAN2A2 RAPH1 ARL8B USP9X CFL2 KTN1 SYNE2 ENPP5 CDC5L DYNC1H1	3.28e-05	946	94	13	M39169
Coexpression	YAGI_AML_FAB_MARKERS	CTR9 ZMYND8 TJP2 MYO16 VCL RYR3	7.22e-05	194	94	6	M5103
Coexpression	GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	MAN2A1 USP9X DNAH17 ZMYND8 DYNC1H1 VCL	8.08e-05	198	94	6	M3242
Coexpression	GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN	PRUNE2 RNPEP CENPF USP9X HERC2 JAKMIP2	8.08e-05	198	94	6	M9882
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	TDRD7 MYO1E TRIM35 IFT172 KTN1 ARL8A	8.30e-05	199	94	6	M7156
Coexpression	GSE30083_SP1_VS_SP4_THYMOCYTE_DN	TDRD7 CCDC88C TRAF5 SYNE2 IFT80 ALS2CL	8.54e-05	200	94	6	M5030
Coexpression	GSE30083_SP2_VS_SP4_THYMOCYTE_DN	CCDC88C TRAF5 SYNE2 TJP2 ALS2CL TF	8.54e-05	200	94	6	M5035
Coexpression	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP	PTCHD1 ZNF569 SYNE2 ZMYND8 ECE1 TF	8.54e-05	200	94	6	M8099
Coexpression	GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP	TRAF5 SYDE2 ASL LETM1 VCL BRWD1	8.54e-05	200	94	6	M6600
Coexpression	GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN	TDRD7 PIK3AP1 TRAF5 MYO1E SYNE2 BRWD1	8.54e-05	200	94	6	M3790
Coexpression	GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP	TDRD7 MYO1E TRIM35 IFT172 LRRK2 VCL	8.54e-05	200	94	6	M7153
Coexpression	GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN	RAPH1 RBL2 PHACTR4 TF VCL BRWD1	8.54e-05	200	94	6	M4346
Coexpression	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	CFL2 PHACTR4 TF VCL	1.00e-04	67	94	4	M1686
Coexpression	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	CFL2 PHACTR4 TF VCL	1.25e-04	71	94	4	MM1210
Coexpression	KIM_WT1_TARGETS_UP	SPATA2L MYO1E TRIO CARD10 VCL PHLPP2	1.33e-04	217	94	6	M9128
Coexpression	MATZUK_MALE_REPRODUCTION_SERTOLI	MAN2A2 CYP17A1 AR	1.37e-04	28	94	3	MM764
Coexpression	MATZUK_MALE_REPRODUCTION_SERTOLI	MAN2A2 CYP17A1 AR	1.37e-04	28	94	3	M1828
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	BCL11B RAPH1 KALRN TRIM35 CORIN DCLRE1B DMD PREX1	1.78e-04	437	94	8	M15981
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2	KATNAL2 CENPF KTN1 SYNE2 NINL TJP2 JAKMIP2	1.11e-05	173	93	7	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	CCDC88C KATNAL2 KTN1 SYNE2 DMD JAKMIP2	3.37e-05	139	93	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	CCDC88C KATNAL2 CENPF KTN1 SYNE2 NINL DMD JAKMIP2	4.97e-05	298	93	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	SHANK1 PTCHD1 BCL11B RBL2 KTN1 NINL DGKB DMD PPP6R2 JAKMIP2 PHLPP2	7.69e-05	614	93	11	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1
CoexpressionAtlas	NK cells, NK.Sp, NK1.1+, Spleen, avg-3	PIK3AP1 CCDC88C MYO1E RAPH1 TRIO RBL2 CYP17A1 ENPP5 PREX1	7.71e-05	409	93	9	GSM538315_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	CCDC88C KATNAL2 CENPF USP9X SMCHD1 KTN1 SYNE2 VPS50 NINL DMD CDC5L UHRF2 ALS2CL XKR5 TGM5 BRWD1	1.05e-04	1257	93	16	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	TDRD7 STARD13 MAN2A1 MYO1E RAPH1 LRRK2 KANK4 DGKB ENPP5 ACTN4 DMD TF VCL	1.07e-04	872	93	13	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2	SHANK1 CCDC88C PTCHD1 KTN1 NINL DMD JAKMIP2	1.10e-04	248	93	7	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	SHANK1 KATNAL2 PTCHD1 CENPF RBL2 KTN1 SYNE2 NINL DGKB DMD PPP6R2 JAKMIP2 PHLPP2	1.36e-04	893	93	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	PRUNE2 PTCHD1 TRAF5 MYO1E KALRN DMD VCL RYR3	6.56e-09	188	94	8	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	PRUNE2 PTCHD1 TRAF5 MYO1E KALRN DMD RYR3	1.55e-07	189	94	7	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E TRIO SYNE2 NINL ACTN4 LRP1B VCL	1.55e-07	189	94	7	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E TRIO SYNE2 NINL ACTN4 LRP1B VCL	1.55e-07	189	94	7	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 PTCHD1 HTR2B CFL2 DGKB VCL RYR3	1.79e-07	193	94	7	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 PRUNE2 PTCHD1 HTR2B CFL2 DGKB VCL	1.85e-07	194	94	7	d2bafd31bb8333f66b6c714944bceb2f1aa11740
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO1E CASKIN2 CFL2 SMCHD1 SYNE2 AFDN ECE1	2.28e-07	200	94	7	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E SPTB ALS2CL JAKMIP2 RYR3	2.15e-06	178	94	6	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN DGKB DMD LRP1B MYO16 RYR3	2.60e-06	184	94	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN DGKB DMD LRP1B MYO16 RYR3	2.60e-06	184	94	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN DGKB DMD LRP1B MYO16 RYR3	2.60e-06	184	94	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYO1E KALRN CASKIN2 NINL AFDN CARD10	2.77e-06	186	94	6	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E SPTB ACTN4 ALS2CL RYR3	2.86e-06	187	94	6	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 PRUNE2 CFL2 DMD VCL RYR3	2.86e-06	187	94	6	3912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 CCDC88C TRAF5 DMD LRP1B RYR3	3.13e-06	190	94	6	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 SYDE2 DMD VCL	3.23e-06	191	94	6	de2cd94ee88a7754f86d39469e38374d668210c7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 DMD VCL RYR3	3.33e-06	192	94	6	d0fb6885f023d55a2b7984c99db9c6463258f788
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 PRUNE2 HTR2B CFL2 DMD VCL	3.43e-06	193	94	6	173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SYNE2 PHACTR4 NINL AFDN PCCA	3.53e-06	194	94	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CASKIN2 KTN1 SYNE2 AFDN ECE1 DYNC1H1	4.21e-06	200	94	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO KTN1 SYNE2 AFDN ECE1 BRWD1	4.21e-06	200	94	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CASKIN2 KTN1 SYNE2 AFDN ECE1 DYNC1H1	4.21e-06	200	94	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CASKIN2 SMCHD1 KTN1 SYNE2 AFDN DYNC1H1	4.21e-06	200	94	6	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRUNE2 KLK6 CFL2 DNAH17 TJP2 TF	4.21e-06	200	94	6	829978708463a7459fe1041bd90196775bc4b531
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 PTCHD1 SYNE2 LRRK2 KANK4	1.11e-05	138	94	5	a88c3ae56b0af60f6e87cabade4f21e2bbb336f2
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	TRAF5 KALRN CFL2 DMD RYR3	1.83e-05	153	94	5	ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL11B ATP7A SYNE2 HERC2 BRWD1	2.34e-05	161	94	5	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	LV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	PTCHD1 TRAF5 KALRN DGKB DMD	2.63e-05	165	94	5	f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E ALS2CL JAKMIP2 RYR3	2.87e-05	168	94	5	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	COVID-19-Heart-Adipocyte\|Heart / Disease (COVID-19 only), tissue and cell type	PLIN4 PRUNE2 NINL ENPP5 RYR3	2.95e-05	169	94	5	bd39f85b48207955f80ca120a11e15a0124117b9
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SHANK1 BCL11B RBL2 NINL RYR3	3.04e-05	170	94	5	9a18756e6721980d4b6c37bb52ddfe93ca79c5ab
ToppCell	CTRL-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	SMCHD1 SYNE2 LRRK2 ECE1 PREX1	3.04e-05	170	94	5	151dabe1d240dde414c881bf4fa816c69fa1c32d
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SHANK1 BCL11B RBL2 NINL RYR3	3.12e-05	171	94	5	61d622153b91702ef21b0efc7b9581e592b7ccea
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-Progen\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SHANK1 BCL11B RBL2 NINL RYR3	3.12e-05	171	94	5	09b3fa120f63c411f8a0dd6bd230a9720ce83fb1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC88C BCL11B RBL2 SMCHD1 SYNE2	3.12e-05	171	94	5	e1fe07652c10c37191d1471ddaea500f74269e0c
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	PRUNE2 PTCHD1 TRAF5 MYO1E KALRN	3.12e-05	171	94	5	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	CTRL-Myeloid-Neutrophil\|CTRL / Disease state, Lineage and Cell class	SMCHD1 SYNE2 LRRK2 ECE1 PREX1	3.21e-05	172	94	5	ef3a6fe3b7300959f9f71130200c7fb8741c42b0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E ALS2CL JAKMIP2 RYR3	3.21e-05	172	94	5	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	PRUNE2 KALRN DGKB DMD RYR3	3.30e-05	173	94	5	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E ALS2CL JAKMIP2 RYR3	3.39e-05	174	94	5	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC88C BCL11B RBL2 SMCHD1 SYNE2	3.49e-05	175	94	5	8269721389a3ce98681460e6393f2cff816eaa25
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KLK6 MYO1E ALS2CL JAKMIP2 RYR3	3.68e-05	177	94	5	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SPTB ALS2CL JAKMIP2 RYR3	3.89e-05	179	94	5	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 CFL2 SYDE2 DMD VCL	3.89e-05	179	94	5	e860dca9b28ac5af61804bfd729cd39257cdb352
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	STARD13 KALRN CASKIN2 LRP1B PREX1	3.99e-05	180	94	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	Adult-Immune-natural_killer_cell-D175\|Adult / Lineage, Cell type, age group and donor	CCDC88C TRAF5 BCL11B SYNE2 PREX1	3.99e-05	180	94	5	fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCell	COPD-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	CCDC88C BCL11B SMCHD1 SYNE2 UHRF2	3.99e-05	180	94	5	51a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SPTB ALS2CL JAKMIP2 RYR3	4.10e-05	181	94	5	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SPTB ALS2CL JAKMIP2 RYR3	4.10e-05	181	94	5	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 PRUNE2 HTR2B CFL2 VCL	4.20e-05	182	94	5	7b86703559438e2d5ef3dad963ee0d772513f313
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	PRUNE2 TRAF5 MYO1E KALRN DMD	4.32e-05	183	94	5	818fd886e0188091310825f9145fa53328f2c979
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIO USP9X SMCHD1 SYNE2 PHACTR4	4.32e-05	183	94	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 PTCHD1 CFL2 DMD VCL	4.32e-05	183	94	5	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	PRUNE2 TRAF5 MYO1E KALRN DMD	4.32e-05	183	94	5	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 BCL11B NINL PCCA LRP1B	4.43e-05	184	94	5	e8238fe58f94b4f5700ab7f343fb06ea61e899a9
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	CCDC88C BCL11B SMCHD1 SYNE2 PREX1	4.78e-05	187	94	5	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKB ACTN4 PCCA LRP1B VCL	4.78e-05	187	94	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 CCDC88C TRAF5 DMD RYR3	4.91e-05	188	94	5	74f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 CCDC88C TRAF5 DMD RYR3	4.91e-05	188	94	5	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	PLIN4 PRUNE2 KANK4 LRP1B PDXK	4.91e-05	188	94	5	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3AP1 PRUNE2 SYNE2 LRRK2 PDXK	5.03e-05	189	94	5	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 CCDC88C TRAF5 DMD RYR3	5.03e-05	189	94	5	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKB ACTN4 PCCA LRP1B VCL	5.03e-05	189	94	5	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PTCHD1 DGKB CORIN PHLPP2	5.03e-05	189	94	5	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PTCHD1 DGKB CORIN PHLPP2	5.03e-05	189	94	5	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	CCDC88C SMCHD1 LRRK2 ECE1 VCL	5.16e-05	190	94	5	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL11B RBL2 SYNE2 UHRF2 PREX1	5.16e-05	190	94	5	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 CFL2 SYDE2 DMD VCL	5.16e-05	190	94	5	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFDN ACTN4 ALS2CL MYO16 VCL	5.16e-05	190	94	5	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	CCDC88C BCL11B SMCHD1 SYNE2 PREX1	5.16e-05	190	94	5	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC88C BCL11B RBL2 SMCHD1 SYNE2	5.29e-05	191	94	5	912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RNPEP CFL2 ENPP5 DYNC1H1 VCL	5.29e-05	191	94	5	cadb7a9de16f4bb21606de0e25cddd2d748c7f0b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC88C BCL11B RBL2 SMCHD1 SYNE2	5.29e-05	191	94	5	77a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	CCDC88C BCL11B CENPF SMCHD1 SYNE2	5.29e-05	191	94	5	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	RNPEP CFL2 ECE1 DYNC1H1 VCL	5.42e-05	192	94	5	efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 DMD VCL	5.56e-05	193	94	5	a402e736440684ebe123673b6b0c6fcd8fa057b2
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCL11B ENPP3 SMCHD1 SYNE2 BRWD1	5.56e-05	193	94	5	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 DMD VCL	5.56e-05	193	94	5	b1893193766ae41bf2ab6ed4083285c9c814e608
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRUNE2 KLK6 CFL2 TJP2 TF	5.56e-05	193	94	5	947200ef6c3a2e35ad7e6b4af29d92384bdf73f5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E RAPH1 TRIO LRP1B VCL	5.69e-05	194	94	5	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCDC88C TRAF5 BCL11B SMCHD1 SYNE2	5.69e-05	194	94	5	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E RAPH1 TRIO LRP1B VCL	5.69e-05	194	94	5	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 DMD VCL	5.69e-05	194	94	5	93bc72a933ccc6a760e5353f072afb606571c6fc
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HTR2B CFL2 DMD VCL	5.69e-05	194	94	5	bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec
ToppCell	COVID-19-lung-CD4+_T_cells_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	CCDC88C TRAF5 BCL11B SMCHD1 SYNE2	5.69e-05	194	94	5	2a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 TRAF5 HTR2B CFL2 VCL	5.83e-05	195	94	5	26a3a5daf389606ef1ebb35533f12e60853b3a12
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CCDC88C BCL11B RBL2 SYNE2 JAKMIP2	5.98e-05	196	94	5	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCDC88C BCL11B SYNE2 ACTN4 JAKMIP2	5.98e-05	196	94	5	51c750a0fb2b87e17e62b984c91fb16f676d7e76
ToppCell	severe_influenza-CD8+_Tem\|World / disease group, cell group and cell class (v2)	BCL11B RBL2 SYNE2 ENPP5 JAKMIP2	5.98e-05	196	94	5	40fb254abcab2e65affc5d6037e71893a031d264
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CCDC88C BCL11B RBL2 SYNE2 JAKMIP2	6.12e-05	197	94	5	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCL11B ENPP3 SMCHD1 SYNE2 UHRF2	6.12e-05	197	94	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 TRAF5 HTR2B CFL2 VCL	6.12e-05	197	94	5	ba6393671a980a1d439307601d18db70a1b1e1f3
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCDC88C BCL11B SMCHD1 SYNE2 ECE1	6.12e-05	197	94	5	927bf36bad3bcb7346c13b660777c1c0de7dc322
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCDC88C BCL11B SMCHD1 SYNE2 ECE1	6.12e-05	197	94	5	3e09158507df08c08e08613ce23617206280c911
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 TRAF5 HTR2B CFL2 VCL	6.12e-05	197	94	5	5a63c2b824c7d0dbbc706e408459c9b9fe65daaa
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CCDC88C BCL11B RBL2 SYNE2 JAKMIP2	6.12e-05	197	94	5	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	COVID-19_Moderate-CD4+_CTL\|World / disease group, cell group and cell class	BCL11B RBL2 SYNE2 AFDN JAKMIP2	6.42e-05	199	94	5	12ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CCDC88C TRAF5 BCL11B RBL2 SYNE2	6.42e-05	199	94	5	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	Macroglial-Oligodendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PRUNE2 KLK6 MAN2A1 MYO1E TF	6.58e-05	200	94	5	4dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CASKIN2 SMCHD1 SYNE2 AFDN DYNC1H1	6.58e-05	200	94	5	89821a264e872ed53e08e9d3609d5cc5c314503e
Drug	S 105	SPTB DMD VCL	1.46e-05	12	94	3	CID000031154
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	SPATA2L MAN2A2 CYP17A1 DNAH17 VPS50 ZMYND8 LETM1	1.66e-05	195	94	7	7048_UP
Drug	4,16-androstadien-3-one	CYP17A1 AR	1.69e-05	2	94	2	ctd:C003524
Drug	20-hydroximino-4,16-pregnadien-3-one	CYP17A1 AR	1.69e-05	2	94	2	ctd:C116515
Drug	androsta-5,16-dien-3 beta-ol	CYP17A1 AR	1.69e-05	2	94	2	ctd:C000152
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; HL60; HT_HG-U133A	SPATA2L CENPF DCLRE1B PPP6R2 ALS2CL TTC33 BBOF1	1.71e-05	196	94	7	2521_DN
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A	STARD13 TRIO CEP250 ZMYND8 AFDN ECE1 ALS2CL	1.71e-05	196	94	7	2837_UP
Drug	AC1L1IZE	AARS1 RBL2 DNAH17 DYNC1H1 PDXK RYR3	1.74e-05	131	94	6	CID000004799
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; PC3; HT_HG-U133A	TDRD7 MIA3 MYO1E CEP250 CDC5L ECE1 ALS2CL	1.77e-05	197	94	7	6325_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	BCL11B TRIO SMCHD1 SPTB ZMYND8 LETM1 BRWD1	1.89e-05	199	94	7	4316_DN
Disease	Malignant neoplasm of breast	RAPH1 KALRN CENPF ZNF569 CFL2 CYP17A1 ASL KTN1 SYNE2 HERC2 DMD ALS2CL AR	3.20e-05	1074	93	13	C0006142
Disease	migraine disorder	CENPF ZMYND8 TJP2 TRPM8 ACTN4 DMD CDC5L	1.39e-04	357	93	7	MONDO_0005277
Disease	Mental Retardation, X-Linked 1	PTCHD1 USP9X DMD	1.41e-04	32	93	3	C2931498
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	SYNE2 CORIN	2.04e-04	7	93	2	EFO_0800551
Disease	Inherited focal segmental glomerulosclerosis	MYO1E ACTN4	4.35e-04	10	93	2	cv:CN327126
Disease	Focal segmental glomerulosclerosis	MYO1E ACTN4	4.35e-04	10	93	2	cv:C0017668
Disease	red blood cell density measurement	STARD13 BCL11B KALRN TJP2 AFDN UHRF2 TF PREX1 MYO16 TTC33	4.58e-04	880	93	10	EFO_0007978
Disease	Male sterility	TDRD7 CYP17A1 AR	4.73e-04	48	93	3	C0917731
Disease	Male infertility	TDRD7 CYP17A1 AR	4.73e-04	48	93	3	C0021364
Disease	Subfertility, Male	TDRD7 CYP17A1 AR	4.73e-04	48	93	3	C0848676
Disease	Polydactyly	CENPF USP9X IFT172 IFT80	5.22e-04	117	93	4	C0152427
Disease	Jeune thoracic dystrophy	IFT172 IFT80	5.31e-04	11	93	2	C0265275
Disease	amino acid metabolic disorder (is_implicated_in)	ASL PCCA	5.31e-04	11	93	2	DOID:9252 (is_implicated_in)
Disease	Hereditary Nephrotic Syndromes, Autosomal Dominant	MYO1E ACTN4	5.31e-04	11	93	2	cv:CN043612
Disease	seasonality measurement	TJP2 MYO16	6.35e-04	12	93	2	EFO_0006876
Disease	body mass index, osteoarthritis	RAPH1 CDC5L BRWD1	6.69e-04	54	93	3	EFO_0004340, MONDO_0005178
Disease	Sarcomatoid Renal Cell Carcinoma	SHANK1 SYNE2 LRRK2 LRP1B	7.32e-04	128	93	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	SHANK1 SYNE2 LRRK2 LRP1B	7.32e-04	128	93	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	SHANK1 SYNE2 LRRK2 LRP1B	7.32e-04	128	93	4	C1266044
Disease	Papillary Renal Cell Carcinoma	SHANK1 SYNE2 LRRK2 LRP1B	7.32e-04	128	93	4	C1306837
Disease	Renal Cell Carcinoma	SHANK1 SYNE2 LRRK2 LRP1B	7.32e-04	128	93	4	C0007134
Disease	Familial idiopathic steroid-resistant nephrotic syndrome	MYO1E ACTN4	7.49e-04	13	93	2	cv:C4273714
Disease	putamen volume change measurement	SYDE2 MYO16	7.49e-04	13	93	2	EFO_0021495
Disease	gallbladder cancer (is_implicated_in)	CYP17A1 LRP1B	7.49e-04	13	93	2	DOID:3121 (is_implicated_in)
Disease	myocardial infarction	MIA3 KALRN CYP17A1 DGKB DCLRE1B PKD1L3	8.55e-04	350	93	6	EFO_0000612
Disease	Profound Mental Retardation	PTCHD1 ELP2 DYNC1H1 LETM1	9.95e-04	139	93	4	C0020796
Disease	Mental Retardation, Psychosocial	PTCHD1 ELP2 DYNC1H1 LETM1	9.95e-04	139	93	4	C0025363
Disease	Mental deficiency	PTCHD1 ELP2 DYNC1H1 LETM1	9.95e-04	139	93	4	C0917816
Disease	preeclampsia, hypertension, pregnancy-induced	ACTN4 PREX1	1.15e-03	16	93	2	EFO_0000668, MONDO_0024664
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	SHANK1 SYNE2 LRRK2 LRP1B	1.26e-03	148	93	4	C0279702
Disease	Charcot-Marie-Tooth disease type 2	AARS1 DYNC1H1	1.30e-03	17	93	2	cv:C0270914
Disease	autism spectrum disorder (implicated_via_orthology)	SHANK1 HTR2B ELP2 PREX1	1.38e-03	152	93	4	DOID:0060041 (implicated_via_orthology)
Disease	glaucoma	KALRN HERC2 CDC5L LRP1B	1.45e-03	154	93	4	MONDO_0005041
Disease	white matter microstructure measurement	SPATA2L RAPH1 ACTN4 CDC5L ECE1 TF	1.49e-03	390	93	6	EFO_0005674
Disease	epilepsy (implicated_via_orthology)	TRIO KALRN LRP1B DYNC1H1	1.79e-03	163	93	4	DOID:1826 (implicated_via_orthology)
Disease	haptoglobin measurement	PKD1L3 PHLPP2	1.98e-03	21	93	2	EFO_0004640
Disease	longevity	RAPH1 KALRN SYDE2 ECE1 PREX1	2.08e-03	284	93	5	EFO_0004300
Disease	COVID-19, mortality	DGKB ELP2 JAKMIP2 LRP1B	2.08e-03	170	93	4	EFO_0004352, MONDO_0100096
Disease	alcohol drinking	TDRD7 TRPM8 TF	2.16e-03	81	93	3	EFO_0004329
Disease	blood pressure	PREX1 MYO16	2.18e-03	22	93	2	EFO_0004325
Disease	waist circumference	TRIO CYP17A1 SYNE2 ACTN4 DMD PREX1	2.40e-03	429	93	6	EFO_0004342
Disease	Intellectual Disability	PTCHD1 BCL11B TRIO ELP2 DYNC1H1 LETM1	2.94e-03	447	93	6	C3714756
Disease	nevus count, cutaneous melanoma	MIA3 SYNE2 HERC2	3.01e-03	91	93	3	EFO_0000389, EFO_0004632
Disease	colorectal cancer	STARD13 BCL11B CYP17A1 HERC2 PREX1 MYO16 TTC33	3.02e-03	604	93	7	MONDO_0005575

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQLGHIEAWAEKQGL	AFDN	821	P55196
KQELDQAVATQALWH	ALS2CL	201	Q60I27
IVEEQGNKLHWAALL	HTR2B	46	P41595
CQKLHAVQGELQWAE	CARD10	336	Q9BWT7
NDLWDQIEQAHLELR	CDC5L	736	Q99459
GQIVLKNDHQEDFWK	RNPEP	576	Q9H4A4
VGEHILKEGLTIWNQ	AKAP4	496	Q5JQC9
SDINNGWQHLEQAEK	ACTN4	381	O43707
KQWQDLQGEIEAHTD	DMD	2736	P11532
NVDEAVLHFKEWQLN	PIK3AP1	621	Q6ZUJ8
QDLLEAEKWTHIEGN	BBOF1	421	Q8ND07
KQWIQALEVGESHVL	DCLRE1B	66	Q9H816
GVEQFEDIWQKLHNA	CNOT3	21	O75175
IEGLLHKNNWNIEDN	ATP7A	1126	Q04656
IFEDHENLVENLLNW	RAPH1	326	Q70E73
LNQIEEQILDHLAWK	RBL2	586	Q08999
EKDNIDITLQWLIQH	ARL8B	166	Q9NVJ2
EKDNIDITLQWLIQH	ARL8A	166	Q96BM9
DGRQLWLEVKNIEEH	KIAA0100	1646	Q14667
WIQQIEGAEAALHQK	JAKMIP2	666	Q96AA8
AHFGNIQLIKDNWED	LRP1B	2246	Q9NZR2
FALIDQLIEGHQWLE	MAN2A1	261	Q16706
RKLCEEGQDWQQILH	MYO16	1806	Q9Y6X6
GLHDLNVQCDWQQKG	HERC2	2601	O95714
DQILHGLDKVAEEWA	ASL	61	P04424
GQLKQWLDLHLHQEI	LETM1	396	O95202
HLGWELEQLSKNADL	CCDC88C	431	Q9P219
IKHEWQVNGLDDIKD	CFL2	131	Q9Y281
LHNPNIKWNDIIGLD	KATNAL2	246	Q8IYT4
IIAVADEGWHILQNK	ENPP5	316	Q9UJA9
QQVLDWIENHGEAFL	KALRN	546	O60229
QLRHLQAEVKQVLGW	KALRN	891	O60229
GNDWEVLGVHQLILK	LRRK2	106	Q5S007
WLQDLQEENESLKAH	KTN1	896	Q86UP2
NELGERQLVHVVKWA	AR	706	P10275
EIQVLGDKHGNALWL	PCCA	271	P05165
KEEWNEIRHQIGNTL	PHACTR4	571	Q8IZ21
LEGKDAQAIHNWLSE	CASKIN2	486	Q8WXE0
LEEAWGDHLVQQKQL	IFT172	856	Q9UG01
AHDGIILKVDWNSVN	IFT80	186	Q9P2H3
WHGEHLLTNDVKIEQ	BCL11B	876	Q9C0K0
LSQVEGEHQLWKEQN	CENPF	2541	P49454
GEHQLWKEQNLELRN	CENPF	2546	P49454
ALDVAAEKGHWVILQ	DNAH17	3921	Q9UFH2
IDKVHLFVDQQWLAV	ENPP3	456	O14638
EVIINLWALHHNEKE	CYP17A1	391	P05093
QQHDQWEEEGKALRQ	CEP250	421	Q9BV73
DAWSLIGNLHLAKQE	CTR9	566	Q6PD62
ENNVKDDGQHVWRLK	DGKB	236	Q9Y6T7
QGEVKWALEHQEARQ	CCDC78	166	A2IDD5
AAVWKVVLGINNLDH	CORIN	851	Q9Y5Q5
QLLPKRLDWEGNEHN	BRWD1	46	Q9NSI6
FALIDQLIEGHQWLE	MAN2A2	261	P49641
LGQIWDVDLQKNEAI	DYNC1H1	1431	Q14204
KIQELLQEQWNCLEH	KANK4	566	Q5T7N3
EQWIEKDLVHTEGQL	HSPB11	86	Q9Y547
NLWEHNQAIIKHLLE	ECE1	151	P42892
QVIHWEIEDNQLLKA	ELP2	86	Q6IA86
EIEKLQWLHQQELSE	ZMYND8	966	Q9ULU4
AGLRQDVLHWLNEEK	PPP6R2	176	O75170
EGVHQAWQGLEQLLE	PLIN4	1321	Q96Q06
EQWENSLHGLDINQE	SYDE2	796	Q5VT97
LDNIWAAQAGKHEAI	USP9X	431	Q93008
QHVNGLQEVVDDWSK	STARD13	491	Q9Y3M8
AIAKHNQVEAAWLEG	TRIM35	171	Q9UPQ4
GQKAIQIKHQDEVNW	SMCHD1	1046	A6NHR9
QIKHQDEVNWIAGDI	SMCHD1	1051	A6NHR9
WQILVEDFDLHGALQ	SPATA2L	36	Q8IUW3
LEGNGKNSHEQLWNI	PRUNE2	1896	Q8WUY3
DGLDHQINAWKIKLN	SYNE2	371	Q8WXH0
LESQIKQLEHGWEQV	SYNE2	2596	Q8WXH0
EQLQQEIEDWSKLHA	MIA3	1361	Q5JRA6
WVKNALEVHGVAILQ	PTCHD1	786	Q96NR3
GFLAHIWNKEVQDLI	PKD1L3	56	Q7Z443
KLEALEQLQSHIEGW	PREX1	246	Q8TCU6
KEDLNQGILQQFEHW	TDRD7	266	Q8NHU6
ELHEKSQEVIWGLQE	NINL	681	Q9Y2I6
HWKGQVLNSDELQEL	PDXK	51	O00764
IDKSAWLEAQVHQLL	TRAF5	316	O00463
QLGIADENGWQEIHQ	SHANK1	306	Q9Y566
NQKLWDEVLSHLVEG	UHRF2	706	Q96PU4
EHGLTRIWQDVQLKV	VPS50	381	Q96JG6
LKDTIQHQQGEAVWV	TJP2	871	Q9UDY2
LIWELLNQAQEHFGK	TF	281	P02787
LEADLECKQIWQNLG	AARS1	146	P49588
QDELLILGNKALWEH	PHLPP2	976	Q6ZVD8
WLVHLQQVERQIKEG	SEC16A	1876	O15027
ILVDKLAENAHNVWA	RYR3	981	Q15413
VHLEGKIEQAQRWID	VCL	491	P18206
DIGQRQKHLEELWQG	SPTB	1031	P11277
QKHLEELWQGLQQSL	SPTB	1036	P11277
WLVQGGKEQKLHQDT	TGM5	406	O43548
EIWGVDEHQKNQDRL	ZNF569	81	Q5MCW4
RQEQGAENEELHQLW	TTC37	146	Q6PGP7
QDKDNWNGQLKLLLE	TRPM8	421	Q7Z2W7
QKELEAPHRGWLQLQ	XKR5	91	Q6UX68
IAWDNQGLLHELQND	ZP4	56	Q12836
QQVLDWIENHGEAFL	TRIO	576	O75962
HLQAEVKQVLGWIRN	TRIO	911	O75962
QNILYHLGEEWQKLI	ZW10	171	O43264
DVVDNDEGNWLHAIK	TTC33	31	Q6PID6
IAAAWAEEQNKLVHG	KLK6	11	Q92876
SWQGEEKQGVLHLLQ	MYO1E	646	Q12965